Suppr超能文献

增殖性糖尿病视网膜病变患者玻璃体液和视网膜前膜中的心房利钠肽。

Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.

作者信息

Rollin Raquel, Mediero Aránzazu, Martínez-Montero Juan Carlos, Roldán-Pallarés Manuela, Suárez-Leoz Marta, Vidal-Fernández Pilar, Cortés-Valdés Carlos, Fernández-Cruz Arturo, Fernández-Durango Raquel

机构信息

Unidad de Investigación, Departamento de Medicina Interna III, Hospital Clinico San Carlos, Madrid, Spain.

出版信息

Mol Vis. 2004 Jul 15;10:450-7.

Abstract

PURPOSE

Atrial natriuretic peptide (ANP) has been recently described as an endogenous inhibitor of the synthesis and angiogenic action of vascular endothelial growth factor (VEGF). Given VEGF's key role in promoting neovascularization in proliferative diabetic retinopathy (PDR), this study was designed to evaluate the possibility that ANP could be involved in the neovascular and fibrotic complications of PDR.

METHODS

We determined ANP by radioimmunoassay in plasma and vitreous humor samples collected from diabetic patients with and without PDR and from non-diabetic subjects. ANP was also immunohistochemically localized in the epiretinal membranes of patients with PDR.

RESULTS

Vitreous ANP concentrations were significantly higher in patients with active PDR compared to patients with quiescent PDR, diabetes without PDR or controls <0.05. Significant differences were also observed between vitreous ANP levels in diabetic patients without PDR and control subjects. There was no significant correlation between serum and vitreous ANP levels in any of the patient groups. ANP was detected in the fibrovascular epiretinal tissue of patients with PDR.

CONCLUSIONS

Diabetic patients with active neovascularization have significantly higher levels of ANP in the vitreous humor than those without active PDR. Diabetic patients without PDR were also found to have significantly higher vitreous ANP levels than non-diabetic patients. Since plasma and vitreous ANP concentrations were found to be unrelated, we suggest intraocular ANP synthesis and/or an increase in the release of ANP into the vitreous, as opposed to diffusion from the blood, as the main factors contributing to the high vitreous ANP levels observed in diabetic patients. In the fibrovascular epiretinal tissue of these patients, ANP was found to be localized in vascular, glial, fibroblast-like and retinal pigment epithelium cells. Our findings suggest a role for ANP in PDR.

摘要

目的

心房利钠肽(ANP)最近被描述为血管内皮生长因子(VEGF)合成及血管生成作用的内源性抑制剂。鉴于VEGF在增殖性糖尿病视网膜病变(PDR)中促进新生血管形成方面的关键作用,本研究旨在评估ANP参与PDR新生血管和纤维化并发症的可能性。

方法

我们采用放射免疫分析法测定了从患有和未患有PDR的糖尿病患者以及非糖尿病受试者采集的血浆和玻璃体液样本中的ANP。还通过免疫组织化学方法对PDR患者的视网膜前膜中的ANP进行了定位。

结果

与静止期PDR患者、无PDR的糖尿病患者或对照组相比,活动期PDR患者的玻璃体液ANP浓度显著更高(P<0.05)。在无PDR的糖尿病患者与对照组受试者的玻璃体液ANP水平之间也观察到显著差异。在任何患者组中,血清和玻璃体液ANP水平之间均无显著相关性。在PDR患者的纤维血管性视网膜前组织中检测到了ANP。

结论

有活动期新生血管形成的糖尿病患者玻璃体液中的ANP水平显著高于无活动期PDR的患者。还发现无PDR的糖尿病患者玻璃体液中的ANP水平显著高于非糖尿病患者。由于发现血浆和玻璃体液中的ANP浓度无关,我们认为眼内ANP的合成和/或ANP向玻璃体液中的释放增加,而非从血液中扩散,是导致糖尿病患者玻璃体液中ANP水平升高的主要因素。在这些患者的纤维血管性视网膜前组织中,发现ANP定位于血管、神经胶质、成纤维细胞样和视网膜色素上皮细胞中。我们的研究结果提示ANP在PDR中发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验